UK markets closed

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
113,900.00-3,700.00 (-3.15%)
At close: 03:30PM KST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,633,971,650
1,626,643,816
1,711,312,740
1,537,825,750
1,504,115,279
Cost of revenue
1,162,396,916
1,142,011,053
1,129,508,276
1,017,232,478
1,063,488,669
Gross profit
471,574,734
484,632,763
581,804,463
520,593,272
440,626,609
Operating expenses
Research development
-
173,487,000
191,347,000
146,030,000
137,987,000
Selling general and administrative
201,819,177
134,402,593
165,070,797
169,126,651
145,241,084
Total operating expenses
-
450,191,593
500,540,797
446,857,651
390,342,084
Operating income or loss
134,434,155
34,441,170
81,263,666
73,735,621
50,284,525
Interest expense
-
28,483,187
18,392,691
12,501,240
10,354,000
Income before tax
-37,776,540
-27,134,763
85,727,860
172,559,286
104,473,503
Income tax expense
-9,403,294
-7,326,032
16,313,075
35,609,407
15,365,726
Income from continuing operations
-28,373,247
-19,808,731
69,414,785
136,949,879
89,107,777
Net income
-29,491,442
-26,631,783
65,453,134
123,211,806
81,048,858
Net income available to common shareholders
-29,491,442
-26,631,783
65,453,134
123,211,806
81,048,858
Basic EPS
162.00
-
5.74k
10.80k
7.10k
Diluted EPS
162.00
-
5.74k
10.80k
7.10k
Basic average shares
11,414
-
11,413
11,413
11,414
Diluted average shares
11,414
-
11,413
11,413
11,414